<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101275111</journal-id>
<journal-id journal-id-type="pubmed-jr-id">33888</journal-id>
<journal-id journal-id-type="nlm-ta">Annu Rev Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">Annu Rev Pathol</journal-id>
<journal-title-group>
<journal-title>Annual review of pathology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-4006</issn>
<issn pub-type="epub">1553-4014</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30379619</article-id>
<article-id pub-id-type="pmc">6450651</article-id>
<article-id pub-id-type="doi">10.1146/annurev-pathmechdis-012418-013046</article-id>
<article-id pub-id-type="manuscript">NIHMS1012802</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Systems-wide approaches in induced pluripotent stem cell models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Edward</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paik</surname>
<given-names>David T</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Joseph C</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Stanford Cardiovascular Institute, Stanford University, Stanford, CA 94305</aff>
<author-notes>
<corresp id="CR1">Correspondence: <email>joewu@stanford.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>24</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>14</volume>
<fpage>395</fpage>
<lpage>419</lpage>
<!--elocation-id from pubmed: 10.1146/annurev-pathmechdis-012418-013046-->
<abstract id="ABS1">
<p id="P1">Human induced pluripotent stem cells (iPSCs) provide a renewable supply of patient-specific and tissue-specific cells for
cellular and molecular studies of disease mechanisms. Combined with advances in various omics technologies, iPSC models can be
used to profile the expression of genes, transcripts, proteins, and metabolites in relevant tissues. Recently, large panels of
iPSC lines have been derived from hundreds of genetically heterogeneous individuals, further enabling genome-wide mapping to
identify co-expression networks and elucidate gene regulatory networks. Here we review recent developments in omics profiling
various molecular phenotypes, and the emergence of human iPSCs as a systems biology model of human diseases.</p>
</abstract>
<kwd-group>
<kwd>induced pluripotent stem cells</kwd>
<kwd>disease modeling</kwd>
<kwd>transcriptomics</kwd>
<kwd>proteomics</kwd>
<kwd>systems biology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>